Position in CPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,996,939
+$4,688,222 QoQ
Shares Held
201,815
+1425.8% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. CPRX ranks #101 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,099,318 | $363,731,344 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
317,058 | $141,579,078 | |
| 3 | INCY |
Incyte Corp
|
1,253,138 | $117,945,347 | |
| 4 | RPRX |
Royalty Pharma plc
|
2,120,692 | $101,729,594 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,761,437 | $81,247,039 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
628,075 | $66,199,104 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,246,943 | $62,240,320 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
1,600,168 | $61,590,466 |
All Filings in CPRX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,996,939 | 201,815 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $308,717 | 13,227 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $474,829 | 24,103 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $3,055,859 | 140,823 | Shares | Other | 2025-08-13 | |
| 2024-12-31 | $5,293,403 | 253,637 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $17,115,367 | 860,934 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $18,890,628 | 1,219,537 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $26,842,178 | 1,683,951 | Shares | Other | 2024-05-15 | |
| 2023-09-30 | $864,954 | 73,991 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $2,607,400 | 194,003 | Shares | Other | 2023-08-14 | |
| 2021-12-31 | $1,356,085 | 200,308 | Shares | Other | 2022-02-14 | |
| 2021-03-31 | $476,360 | 103,332 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $473,605 | 141,798 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $882,030 | 296,980 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,521,966 | 329,430 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,255,890 | 1,105,426 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||